Wolters Kluwer N V Stock Price, News & Analysis

Wolters Kluwer (Euronext: WTKWY) has reported the latest transactions in its ongoing share buyback program. From June 19-25, 2025, the company repurchased 174,141 shares at an average price of €141.86, totaling €24.7 million.

This is part of the company's €1 billion share buyback program for 2025 announced on February 26. Year-to-date, Wolters Kluwer has repurchased 3,253,150 shares for a total consideration of €502.2 million at an average price of €154.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025.

Wolters Kluwer (WTKWY) has successfully priced a new €500 million five-year senior unsecured Eurobond offering. The bonds were issued at 99.975% of face value with a 3.000% annual coupon rate and will mature on September 25, 2030. The securities, expected to receive an A- rating from S&P Global Ratings, were distributed to various institutional investors across Europe. The settlement date is set for June 30, 2025, and the bonds will be listed on the Luxembourg Stock Exchange's Official List. The company plans to use the net proceeds for general corporate purposes. Barclays, Commerzbank, Deutsche Bank, IMI – Intesa Sanpaolo, and SMBC served as joint active bookrunners for the offering.

Wolters Kluwer (WTKWY) reports the repurchase of 106,400 of its own ordinary shares between June 12-18, 2025, investing €15.6 million at an average price of €146.95 per share. This action is part of a larger €1 billion share buyback program announced on February 26, 2025. Year-to-date, the company has repurchased 3,079,009 shares for €477.5 million at an average price of €155.09. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.

Wolters Kluwer (WTKWY) has reported the latest transactions in its ongoing share buyback program, repurchasing 222,303 ordinary shares between June 5-11, 2025, for €34.4 million at an average price of €154.85 per share. This is part of a larger €1 billion share buyback program announced on February 26, 2025. Year-to-date, the company has repurchased 2,972,609 shares for €461.9 million at an average price of €155.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. All repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.

Wolters Kluwer Legal & Regulatory has successfully completed its acquisition of Brightflag, a global provider of legal spend and matter management software. The completion follows the initial agreement announcement made on May 29, 2025. Brightflag's software solutions specialize in legal spend management and matter management, complementing Wolters Kluwer's legal technology portfolio. The acquisition marks a strategic move by Wolters Kluwer to strengthen its position in the legal technology sector.

Wolters Kluwer (WTKWY) reports the repurchase of 225,452 ordinary shares between May 29-June 4, 2025, at an average price of €155.93, totaling €35.2 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025. Year-to-date, the company has repurchased 2,750,306 shares for €427.5 million at an average price of €155.43. The company has engaged third parties to execute €350 million in buybacks from May 8 to July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.

Wolters Kluwer Health has acquired IntelliLearn Pty Ltd., an Australian provider of online courseware solutions for nursing schools. Founded in 2010 in Adelaide, IntelliLearn offers cloud-based training modules focused on medication safety and medical math content for educational institutions across Australia, New Zealand, Canada, and the U.S. The acquisition brings seven full-time employees and a network of contract workers to Wolters Kluwer. IntelliLearn will be integrated into Wolters Kluwer's Health, Learning, Research & Practice business unit, complementing their Lippincott nursing education portfolio. The deal is expected to achieve return on invested capital above the company's weighted after-tax cost of capital within 3-5 years, with minimal impact on adjusted earnings.

Wolters Kluwer (WTKWY) has appointed Greg Samios as the new CEO of its Health division, effective June 1, 2025. Samios, who brings over 25 years of healthcare experience, succeeds Stacey Caywood, who became a Member of the Executive Board on May 15, 2025.

As Executive Vice President of the Health division's largest business units, Samios has led growth in clinical decision support products like UpToDate and Medi-Span. He spearheaded the integration of generative AI into healthcare products and strengthened partnerships with digital health companies. His previous roles include Executive VP of Legal & Regulatory U.S. at Wolters Kluwer and health-focused positions at Elsevier.

Wolters Kluwer (WTKWY) has reported its latest share buyback transactions for the period of May 22-28, 2025. The company repurchased 226,259 ordinary shares at an average price of €160.75, totaling €36.4 million. This is part of a larger €1 billion share buyback program announced on February 26, 2025.

Year-to-date, Wolters Kluwer has repurchased 2,524,854 shares for a total consideration of €392.3 million at an average price of €155.38. The company has engaged third parties to execute €350 million of buybacks between May 8 and July 28, 2025. The repurchased shares will be held as treasury shares and eventually canceled for capital reduction purposes.